Purpose Several sentinel phase III randomized trials have recently been published
challenging traditional radiation therapy (RT) practices for small cell lung cancer (SCLC) …

Approximately 15% of lung cancer cases are of the small cell subtype, but this variant is
highly aggressive and is often diagnosed at advanced stages. Outcomes after current …

Purpose Brain metastases are common in patients with limited-stage small cell lung cancer
(LS-SCLC) due to the inability of most chemotherapeutics to penetrate the blood–brain …

Small cell lung cancer (SCLC) accounts for approximately 20% of all lung cancers. The main
treatment is chemotherapy (Ch). However, the addition of radiotherapy significantly …

Introduction Prophylactic cranial irradiation (PCI) has proven to decrease the incidence of
brain metastases (BMs), with a modest improvement in survival. Patients and Methods The …

Background It is not clear whether or not the fate of patients suffering from small-cell lung
cancer (SCLC) has improved. To better understand the course of disease, we aimed at …

Objective We investigated the correlation between the number of circulating tumor cells
(CTCs) and whole-body metabolic tumor volume (WBMTV) measured by 18 F …

Radiothérapie des cancers primitifs du poumon - ScienceDirect Skip to main contentSkip to
article Elsevier logo Journals & Books Search RegisterSign in View PDF Download full issue …

肺癌脑转移的诊治进展- PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI
Homepage MyNCBI Homepage Main Content Main Navigation Preview improvements coming …

Small cell lung cancer (SCLC) is an aggressive malignancy with a high propensity for brain
metastases (BM). Limited-stage SCLC (LS-SCLC) can be effectively treated with …